ABCC7 p.Gly314Arg

ClinVar: c.940G>C , p.Gly314Arg ? , not provided
c.941G>T , p.Gly314Val ? , not provided
c.941G>A , p.Gly314Glu ? , not provided
CF databases: c.941G>T , p.Gly314Val (CFTR1) D , This mutation was found in a CF patient homozygous for this mutation. He was diagnosed as CF at 32 years.
c.940G>C , p.Gly314Arg (CFTR1) D , This mutation was detected by chemical mismatch and sequencing. The mutation is a G to C change at nucleotide 1072. This results in a glycine to arginine substitution at amino acid 314 (G314R). It is in exon 7 and it eliminates a DdeI restriction site. This mutation was found in a patient with an American Indian/Caucasian mother and Dutch/French father. This patient has a [delta]F508 mutation on the other chromosomes and is pancreatic insufficient. This mutation was not found in 25 normal chromosomes and 25 CF chromosomes.
c.941G>A , p.Gly314Glu (CFTR1) ? , This mutation, in exon 7 of the CFTR gene, was found by direct sequencing and the second mutation is [delta]F508. The patient is 7 years old. Diagnosis of CF was established at the age of five after severe lung infection. Sweat gland tests were positive. She is receiveing pancreatic enzyme supplements and long-term antibiotic treatment.
Predicted by SNAP2: A: D (85%), C: D (91%), D: D (95%), E: D (66%), F: D (95%), H: D (95%), I: D (95%), K: D (95%), L: D (95%), M: D (95%), N: D (91%), P: D (95%), Q: D (95%), R: D (71%), S: D (80%), T: D (91%), V: D (95%), W: D (95%), Y: D (95%),
Predicted by PROVEAN: A: N, C: N, D: N, E: N, F: N, H: N, I: N, K: N, L: N, M: N, N: N, P: N, Q: N, R: N, S: N, T: N, V: N, W: N, Y: N,

[switch to compact view]
Comments [show]
Publications
[hide] Giannattasio S, Bobba A, Jurgelevicius V, Vacca RA, Lattanzio P, Merafina RS, Utkus A, Kucinskas V, Marra E
Molecular basis of cystic fibrosis in Lithuania: incomplete CFTR mutation detection by PCR-based screening protocols.
Genet Test. 2006 Fall;10(3):169-73., [PMID:17020467]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Mansoura MK, Smith SS, Choi AD, Richards NW, Strong TV, Drumm ML, Collins FS, Dawson DC
Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore.
Biophys J. 1998 Mar;74(3):1320-32., [PMID:9512029]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Dawson DC, Smith SS
Cystic fibrosis transmembrane conductance regulator. Permeant ions find the pore.
J Gen Physiol. 1997 Oct;110(4):337-9., [PMID:9379166]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Nasr SZ, Strong TV, Mansoura MK, Dawson DC, Collins FS
Novel missense mutation (G314R) in a cystic fibrosis patient with hepatic failure.
Hum Mutat. 1996;7(2):151-4., [PMID:8829633]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Zietkiewicz E, Rutkiewicz E, Pogorzelski A, Klimek B, Voelkel K, Witt M
CFTR mutations spectrum and the efficiency of molecular diagnostics in Polish cystic fibrosis patients.
PLoS One. 2014 Feb 26;9(2):e89094. doi: 10.1371/journal.pone.0089094. eCollection 2014., [PMID:24586523]

Abstract [show]
Comments [show]
Sentences [show]